about
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney diseaseAngiotensin converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1-3) non-diabetic chronic kidney diseaseAging, diabetes, and the public health system in the United StatesThe burden of nephrotoxic drug prescriptions in patients with chronic kidney disease: a retrospective population-based study in Southern ItalyAssociation between prediabetes and risk of chronic kidney disease: a systematic review and meta-analysis.Heart-kidney interaction: epidemiology of cardiorenal syndromes.Risk models to predict chronic kidney disease and its progression: a systematic review.A retrospective case-control analysis of the outpatient expenditures for western medicine and dental treatment modalities in CKD patients in Taiwan.'Reality and desire' in the care of advanced chronic kidney disease.Multi-Parametric Evaluation of Chronic Kidney Disease by MRI: A Preliminary Cross-Sectional Study.Risk of end-stage renal disease associated with gout: a nationwide population study.Nephrology care prior to end-stage renal disease and outcomes among new ESRD patients in the USAComparison of the heart failure risk stratification performance of the CKD-EPI equation and the MDRD equation for estimated glomerular filtration rate in patients with Type 2 diabetes.High burden and unmet patient needs in chronic kidney disease.Risk factors for acute kidney injury after hip fracture surgery in the elderly individuals.Improving evidence-based primary care for chronic kidney disease: study protocol for a cluster randomized control trial for translating evidence into practice (TRANSLATE CKD)Early detection of CKD: the benefits, limitations and effects on prognosis.Pharmaceutical cost distribution in childhood chronic kidney disease.Chronic kidney disease: a new look at pathogenetic mechanisms and treatment options.Medicine non-adherence in kidney transplantation.Verotoxigenic Escherichia coli: costs of illness in Canada, including long-term health outcomes.A societal cost-of-illness study of hemodialysis in Lebanon.Equity in Distribution of Health Care Resources; Assessment of Need and Access, Using Three Practical Indicators.
P2860
Q24235834-4A4E74E3-3CC8-4FEE-9A81-3F2B6257B421Q24241947-D49A949A-0D6E-4C14-8255-1D4993054830Q26852929-DF6F736D-563A-4296-8C50-7A0912E58C3BQ28539876-FDB9548A-89EF-4CCC-BE87-8873ADC8C7FFQ30251745-B063E81D-2E77-4508-8F3F-F7635E877FF9Q34479128-C9E93090-AB2D-4BF9-A7FC-8ADE7FC7BBABQ34489517-55533CA7-998C-4F46-AC82-86F6FE234CF1Q35095348-D519B856-DA20-4E8A-8906-36622A397C53Q35574546-25F5FD6C-E242-4C52-A836-D8AB6029544EQ35796544-7B999FE7-DD55-4EDF-945A-2A7E6595FDBEQ36245837-894A937F-67A7-4EB4-A37F-613E403D27D2Q36306793-25386FCD-1759-47FE-9590-26A4ED61C151Q36491269-169119DC-94CE-4E7A-ACF8-7A8749D9B12AQ36500612-380CD870-9DEA-41DA-8C76-5AA3887AE787Q36687363-2E3250DA-A444-4445-8DE7-E7FBDD2936F2Q37115852-B57B85BA-27D2-47D1-A805-107898180504Q37895459-4E297E65-4680-4CD6-AF2D-99CEF80D398AQ38006631-B75F5660-4D87-410F-93D3-714A28F44CBAQ38087529-710EF0EF-2125-4261-BBE2-E4E025131A9FQ38197715-9FAD23B1-4D1C-4711-B461-D471A24E226DQ39257556-9045480A-A984-40CB-B334-B60E26E328DEQ39648902-0CE4B45B-25A6-4439-9982-69A4FB6D4CDAQ40741085-905FA68A-6DD7-4766-AC64-B05AB1FB1BFF
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 March 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Economic burden of chronic kidney disease.
@en
Economic burden of chronic kidney disease.
@nl
type
label
Economic burden of chronic kidney disease.
@en
Economic burden of chronic kidney disease.
@nl
prefLabel
Economic burden of chronic kidney disease.
@en
Economic burden of chronic kidney disease.
@nl
P2860
P1476
Economic burden of chronic kidney disease.
@en
P2093
Chester A Amedia
Samina Khan
P2860
P304
P356
10.1111/J.1365-2753.2007.00883.X
P577
2008-03-24T00:00:00Z